Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

주식 순위 #449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
주가
$763.31
시가총액
$53.31B
변동 (1일)
0.87%
변동 (1년)
8.49%
국가
CH
거래 Lonza Group AG (LONN)

카테고리

Healthcare
Lonza Group AG (LONN)의 EPS
2026 기준 EPS TTM: 0
Lonza Group AG의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Lonza Group AG의 EPS 기록 (2004 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2025 $-4.95 -150.09%
2024 $9.89 -6.37%
2023 $10.56 -40.37%
2022 $17.71 -59.29%
2021 $43.49 234.48%
2020 $13.00 44.08%
2019 $9.02 18.21%
2018 $7.63 -23.92%
2017 $10.03 78.24%
2016 $5.63 6.18%
2015 $5.30 15.51%
2014 $4.59 145.27%
2013 $1.87 -44.92%
2012 $3.40 15.65%
2011 $2.94 -46.58%
2010 $5.50 92.65%
2009 $2.85 -62.63%
2008 $7.64 47.35%
2007 $5.18 45.65%
2006 $3.56 27.31%
2005 $2.80 17.74%
2004 $2.37 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -
US
$-7.98 -
US
$-5.29 -
AU
$27.74 -
NL
$13.70 -
BE